Wells Fargo’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-61
| Closed | -$277 | – | 6904 |
|
|
2024
Q1 | $277 | Buy |
61
+32
| +110% | +$145 | ﹤0.01% | 6026 |
|
|
2023
Q4 | $202 | Buy |
29
+2
| +7% | +$14 | ﹤0.01% | 6166 |
|
|
2023
Q3 | $169 | Buy |
27
+2
| +8% | +$13 | ﹤0.01% | 6252 |
|
|
2023
Q2 | $205 | Buy |
25
+6
| +32% | +$49 | ﹤0.01% | 6385 |
|
|
2023
Q1 | $82 | Hold |
19
| – | – | ﹤0.01% | 6657 |
|
|
2022
Q4 | $109 | Buy |
19
+1
| +6% | +$6 | ﹤0.01% | 6443 |
|
|
2022
Q3 | $0 | Buy |
18
+1
| +6% | – | ﹤0.01% | 6918 |
|
|
2022
Q2 | $0 | Buy |
+17
| New | – | ﹤0.01% | 7059 |
|